Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4574]

Progession free survival benefit of enzalutamide compared to bicalutamide in metastatic castration-resistant prostate cancer

Progession free survival benefit of enzalutamide compared to bicalutamide in metastatic castration-resistant...

Study targets SGEF protein in treating glioblastoma brain tumours

Study targets SGEF protein in treating glioblastoma brain tumours

Long-term survivors of childhood cancer living longer thanks in part to treatment changes

Long-term survivors of childhood cancer living longer thanks in part to treatment changes

Dabrafenib/trametinib in advanced BRAF V600 mutated melanoma: Indication of added benefit

Dabrafenib/trametinib in advanced BRAF V600 mutated melanoma: Indication of added benefit

Regorafenib in metastatic colorectal cancer: Still hint of minor added benefit

Regorafenib in metastatic colorectal cancer: Still hint of minor added benefit

Nivolumab in melanoma: Data subsequently submitted improve assessment result

Nivolumab in melanoma: Data subsequently submitted improve assessment result

USA panel finalises breast cancer screening recommendations

USA panel finalises breast cancer screening recommendations

Cancer-killing proteins destroy tumor cells in bloodstream

Cancer-killing proteins destroy tumor cells in bloodstream

Colorectal cancer more likely to affect minorities at younger age

Colorectal cancer more likely to affect minorities at younger age

Scientists re-engineer body’s immune system for safer and more effective cancer treatment

Scientists re-engineer body’s immune system for safer and more effective cancer treatment

More from ecancer